Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Hits QuantWave Forecast Target with 32.11% Profit Margin

August 08, 2023
ELI LILLY AND COMPANY has successfully reached the price target forecasted by QuantWave, resulting in a significant profit margin of 32.11%. The forecast signal was initiated on April 28, 2023, with a price of 388.39 $. The predicted direction was long, and on August 8, 2023, the stock reached a price of 513.09 $, aligning perfectly with the forecast. This achievement highlights the accuracy and effectiveness of QuantWave's analytics in predicting stock movements.

The success of this forecast can be attributed to various factors such as positive earnings reports, new drug developments, and favorable market conditions within the pharmaceutical industry. Investors who followed the QuantWave forecast for ELI LILLY AND COMPANY were able to capitalize on this opportunity and generate substantial profits.

QuantWave is a leading automated forecasting platform that provides users with predictions for a wide range of stocks, offering lucrative opportunities for potential profits. For those interested in delving deeper into the investment strategy behind QuantWave, exploring the educational resources of QuantSchool is highly recommended. QuantSchool offers a comprehensive professional investment framework that reveals key principles for generating consistent income using the QuantWave forecasting system.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYAugust 12, 2025Eli Lilly and Co LLY Traded Lower in Q2 Despite Good Results  ~1 min.

Eli Lilly and Company, despite reporting good results in the second quarter of this year, saw its stock price traded lower....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 20.09% Profit: QuantWave Achieves Success  ~1 min.

On January 28, 2025, QuantWave, an automated forecasting platform, issued a short signal for ELI LILLY AND COMPANY stock when it was trading at 800.2 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target, Generating 18.65% Profit for QuantWave Users  ~1 min.

ELI LILLY AND COMPANY's stock recently reached the price target forecasted by QuantWave on 2024-08-06. The forecast signal indicated a short position, with the stock priced at 786.06 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Short Price Target Forecast Resulting in 19.15% Profit for QuantWave Users  ~2 min.

ELI LILLY AND COMPANY (LLY) investors recently saw the stock hitting a short price target forecast set by QuantWave, resulting in a substantial profit of 19.15%....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target Resulting in 19.55% Profit - QuantWave Success  ~1 min.

ELI LILLY AND COMPANY stock has successfully reached the price target as forecasted by QuantWave, resulting in a profitable 19.55% gain for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits QuantWave Forecast, Delivering 19.57% Profit  ~1 min.

ELI LILLY AND COMPANY has achieved the price target forecast set by QuantWave, signaling a 19.57% profit for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 22.51% Profit  ~1 min.

ELI LILLY AND COMPANY stock recently achieved its forecasted price target as predicted by QuantWave, a leading automated forecasting platform....


LLYAugust 7, 2025ELI LILLY AND COMPANY Hits Forecast Price Target with 22.13% Profit on QuantWave Platform  ~2 min.

ELI LILLY AND COMPANY (LLY) recently achieved the forecast price target on the QuantWave platform, resulting in a remarkable 22.13% profit for investors who followed the short signal....


LLYAugust 1, 2025Eli Lilly and Company Completes Acquisition of Verve Therapeutics, Advancing One-Time Treatments for High Cardiovascular Risk  ~1 min.

Eli Lilly and Company has announced the successful completion of its acquisition of Verve Therapeutics, a move that will help advance innovative one-time treatments for individuals with high cardiovascular risk. This strategic decision showcases the company's commitment to revolutionizing the healthcare industry and improving patient outcomes. Investors are eagerly watching as Eli Lilly continues ...


LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....


REGNAugust 15, 2024REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 19.37% Profit: QuantWave Analysis  ~2 min.

REGENERON PHARMACEUTICALS, INC. has seen a significant achievement in hitting its price target forecast as predicted by QuantWave, leading to a profit of 19.37%....


LLYMay 3, 2023ELI LILLY AND COMPANY Hits 31.24% Profit Target, QuantWave Forecast Success  ~1 min.

Amidst market volatility, investors received a significant boost as ELI LILLY AND COMPANY reached the predicted price target with a substantial 31....


BCH-USDJuly 11, 2025BITCOIN CASH USD Forecast Success with 32.58% Profit Achieved: QuantWave's Analytics Prove Valuable  ~2 min.

The stock of BITCOIN CASH USD recently hit a significant milestone, as it successfully reached the price target forecasted by QuantWave with a profitable outcome of 32.58% for investors....


LLYAugust 8, 2023ELI LILLY AND COMPANY Stock Hits Forecast Price Target with 19.5% Profit: QuantWave Analysis  ~1 min.

ELI LILLY AND COMPANY stock recently reached the price target forecasted by QuantWave with a profitable outcome of 19.5%. The forecast signal was issued on June 1, 2023, at a price of 430.31 $....


GEJune 4, 2025QuantWave Forecast Success: GE AEROSPACE Hits Price Target with 44.65% Profit  ~2 min.

QuantWave, the automated forecasting platform, saw one of its predictions come to fruition as GE AEROSPACE's stock reached the forecasted target price with a 44.65% profit margin....